Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnoldus

Showing results (141-150 of 145) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 145 results.
Journal of the Neurological Sciences|June 26, 2024
Influence of personalized extended interval dosing on the natalizumab wearing-off effect - a sub-study of the NEXT-MS trialA A Toorop, M H J Wessels, L M Y Gelissen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 14, 2023
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS)Alyssa A Toorop, Zoë Ygj van Lierop, Liza My Gelissen, et al.
Chronic Respiratory Disease|August 5, 2017
Physical activity patterns and clusters in 1001 patients with COPDRafael Mesquita, Gabriele Spina, Fabio Pitta, et al.
Nature|April 3, 2020
Tracking of marine predators to protect Southern Ocean ecosystemsMark A Hindell, Ryan R Reisinger, Yan Ropert-Coudert, et al.
Scientific Data|March 20, 2020
The retrospective analysis of Antarctic tracking data projectYan Ropert-Coudert, Anton P Van de Putte, Ryan R Reisinger, et al.
Pageof 15

Showing results (141-150 of 145) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 145 results.
Journal of the Neurological Sciences|June 26, 2024
Influence of personalized extended interval dosing on the natalizumab wearing-off effect - a sub-study of the NEXT-MS trialA A Toorop, M H J Wessels, L M Y Gelissen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 14, 2023
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS)Alyssa A Toorop, Zoë Ygj van Lierop, Liza My Gelissen, et al.
Chronic Respiratory Disease|August 5, 2017
Physical activity patterns and clusters in 1001 patients with COPDRafael Mesquita, Gabriele Spina, Fabio Pitta, et al.
Nature|April 3, 2020
Tracking of marine predators to protect Southern Ocean ecosystemsMark A Hindell, Ryan R Reisinger, Yan Ropert-Coudert, et al.
Scientific Data|March 20, 2020
The retrospective analysis of Antarctic tracking data projectYan Ropert-Coudert, Anton P Van de Putte, Ryan R Reisinger, et al.
Pageof 15